AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 831.81 | 728.29 | 571.00 | 543.71 | 563.73 |
| Expenses | |||||
| Material consumed | 307.86 | 234.28 | 183.64 | 175.95 | 201.65 |
| Manufacturing expenses | 7.72 | 8.27 | 8.30 | 7.68 | 7.43 |
| Personnel expenses | 216.70 | 197.40 | 153.53 | 162.04 | 169.35 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 178.83 | 217.04 | 179.24 | 161.10 | 168.88 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 711.11 | 656.99 | 524.71 | 506.77 | 547.31 |
| Operating profit | 120.70 | 71.30 | 46.29 | 36.94 | 16.42 |
| Other recurring income | 12.99 | 16.29 | 12.25 | 14.39 | 6.77 |
| Adjusted PBDIT | 133.69 | 87.59 | 58.54 | 51.33 | 23.19 |
| Financial expenses | 1.14 | - | - | - | - |
| Depreciation | 18.58 | 14.92 | 14.74 | 15.83 | 17.43 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 113.97 | 72.67 | 43.80 | 35.50 | 5.76 |
| Tax charges | 41.76 | 18.22 | 17.89 | 15.45 | 0.50 |
| Adjusted PAT | 72.21 | 54.45 | 25.91 | 20.05 | 5.26 |
| Non recurring items | -4.92 | -0.60 | -2.28 | -1.05 | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 67.29 | 53.85 | 23.63 | 19.00 | 5.26 |
| Earnigs before appropriation | 235.38 | 168.22 | 114.37 | 90.74 | 25.53 |
| Equity dividend | 1.99 | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | 0.51 | - | - | - | - |
| Retained earnings | 232.88 | 168.22 | 114.37 | 90.74 | 25.53 |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis